Drug-Pricing Report: Wells Fargo Reports Rise in Price of 60 Drugs
| CLICK HERE and let us show how BHM’s economically maintain turn-around times and accuracy for new members. |
Drugmakers increased the price of 60 products August — a sharp decline from July, which saw 110 price increases, according to a Wells Fargo drug-pricing report.
For its report, analysts at Wells Fargo reviewed PriceRx data from August.
Here are four report findings:
1. The cost of 48 drugs went down in August. In July, 32 drug prices were lowered.
2. The 60 price hikes ranged from 486 percent to 1.6 percent, with a median increase of 9.9 percent.
3. The 48 drug price decreases ranged from 1.5 percent to 88 percent, with a median decrease of 38.6 percent.
4. Seven drugs increased in price by 100 percent or more. Those drugs included: FLUoxetine, Nitrofurantoin, Irbesartan-Hydrochlorothiazide, Valsartan, Thiamine, DilTIAZem and Ondansetron. Many of these drugs are generics.
CLICK HERE and let us show how BHM’s economically maintain turn-around times and accuracy for new members.
Partner with BHM Healthcare Solutions
With over 20 years in the industry, BHM Healthcare Solutions is committed to providing consulting and review services that help streamline clinical, financial, and operational processes to improve care delivery and organizational performance.
We bring the expertise, strategy, and capacity that healthcare organizations need to navigate today’s challenges – so they can focus on helping others.
Are you ready to make the shift to a more effective process?